<i>In Vitro</i> and<i> In Vivo</i> Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/scientifica/volume-2016/6492953/figures/6492953.fig.003a.svgz" name="6492953.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Effect of cholesterol ratio</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/scientifica/volume-2016/6492953/figures/6492953.fig.003b.svgz" name="6492953.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Effect of surfactant ratio</td></tr></table>

<div>Effect of cholesterol and surfactant ratio on particle size of niosomes containing different series of Span.</div>

Scientifica

fig3

Figure 3

Figure 3: <i>In Vitro</i> and<i> In Vivo</i> Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin 

Scientifica

In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin

Figure 3